4
Interagency Patent Coordination and Improvement Act of 2025
7/31/2025, 4:43 AM
Summary of Bill HR 4570
Congressional Summary of HR 4570
Interagency Patent Coordination and Improvement Act of 2025
This bill establishes the Interagency Task Force on Patents to support coordination and communication between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA) on activities relating to patents for human drugs and biological products.
The task force's duties shall include sharing information about (1) the processes of each agency, including how each agency evaluates applications (e.g., patent applications at the USPTO and new drug applications at the FDA); and (2) new approvals of patents, human drugs, biological products, and new technologies. The task force must also establish a process that requires (1) the USPTO to request from the FDA information relating to certain patent applications to help patent examiners carry out their duties, (2) the FDA to provide such information to the USPTO, and (3) the USPTO to assist the FDA in its ministerial role of listing patents.
Read the Full Bill
Current Status of Bill HR 4570
Bipartisan Support of Bill HR 4570
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 4570
Primary Policy Focus
Alternate Title(s) of Bill HR 4570
Comments

Kian Newman
8 months ago
I don't see the point of this bill. Why do we need this? How will this help me in the short term?
